BillionToOne, Inc. Class A (BLLN) Stock Forecast & Price Target

Compare

105 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BLLN Analyst Ratings

Strong Buy

5 Buy

1 Hold

0 Sell

Based on 6 analysts giving stock ratings to

BillionToOne,

Inc. Class A

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BLLN Stock 12 Month Forecast

Average Price Target

$124.00

▲(71.98% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for BillionToOne, Inc. Class A in the last 3 months. The average price target is $124.00 with a high forecast of $150.00 and a low forecast of $90.00. The average price target represents a 71.98% change from the last price of $72.10.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"77":"$77","114":"$114","151":"$151","95.5":"$95.5","132.5":"$132.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":150,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$150.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":124,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$124.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[77,95.5,114,132.5,151],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.65,84.13846153846154,89.62692307692308,95.11538461538461,100.60384615384615,106.09230769230768,111.58076923076923,117.06923076923077,122.5576923076923,128.04615384615386,133.5346153846154,139.02307692307693,144.51153846153846,{"y":150,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.65,82.13846153846154,85.62692307692308,89.11538461538461,92.60384615384616,96.0923076923077,99.58076923076923,103.06923076923077,106.5576923076923,110.04615384615386,113.53461538461539,117.02307692307693,120.51153846153846,{"y":124,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.65,79.52307692307693,80.39615384615385,81.26923076923077,82.1423076923077,83.01538461538462,83.88846153846154,84.76153846153846,85.63461538461539,86.50769230769231,87.38076923076923,88.25384615384615,89.12692307692308,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":108.94,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":108.94,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":108.94,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":108.94,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":108.94,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":108.94,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":108.94,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":108.94,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":108.94,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":113.04,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.84,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.56,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.65,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$150.00

Average Price Target$124.00

Lowest Price Target$90.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Casey Woodring

J.P. Morgan

$145→$120

Buy

66.44%

Upside

Reiterated

03/09/26

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY), BillionToOne, Inc. Class A (NASDAQ: BLLN) and Praxis Precision Medicines (NASDAQ: PRAX)

Brandon Couillard

Wells Fargo

$110→$90

Hold

24.83%

Upside

Assigned

03/05/26

BillionToOne price target lowered to $90 from $110 at Wells FargoBillionToOne price target lowered to $90 from $110 at Wells Fargo

David Westenberg

Piper Sandler

$83.14→$150

Buy

108.04%

Upside

Reiterated

03/05/26

Analysts Are Bullish on These Healthcare Stocks: BillionToOne, Inc. Class A (BLLN), Concentra Group Holdings Parent, Inc. (CON)

Subbu Nambi

Guggenheim

$80.83→$120

Buy

66.44%

Upside

Reiterated

03/05/26

Guggenheim Keeps Their Buy Rating on BillionToOne, Inc. Class A (BLLN)

Andrew Brackmann

William Blair

―

Buy

―

Reiterated

03/05/26

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV), BillionToOne, Inc. Class A (NASDAQ: BLLN) and Solventum Corporation (NYSE: SOLV)

Mark Massaro

BTIG

$160→$140

Buy

94.17%

Upside

Reiterated

03/05/26

BillionToOne price target lowered to $140 from $160 at BTIGBillionToOne price target lowered to $140 from $160 at BTIG

Daniel Arias

Stifel Nicolaus

$145

Buy

101.11%

Upside

Reiterated

12/11/25

BillionToOne, Inc.: Strong Financial Performance and Strategic Market Positioning Drive Buy Rating

Tycho Peterson

Jefferies

$117

Hold

62.27%

Upside

Initiated

12/01/25

Balanced Outlook on BillionToOne, Inc.: High Growth Potential Amidst Competitive Challenges

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Casey Woodring

J.P. Morgan

$145→$120

Buy

66.44%

Upside

Reiterated

03/09/26

Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (NASDAQ: SPRY), BillionToOne, Inc. Class A (NASDAQ: BLLN) and Praxis Precision Medicines (NASDAQ: PRAX)

Brandon Couillard

Wells Fargo

$110→$90

Hold

24.83%

Upside

Assigned

03/05/26

BillionToOne price target lowered to $90 from $110 at Wells FargoBillionToOne price target lowered to $90 from $110 at Wells Fargo

David Westenberg

Piper Sandler

$83.14→$150

Buy

108.04%

Upside

Reiterated

03/05/26

Analysts Are Bullish on These Healthcare Stocks: BillionToOne, Inc. Class A (BLLN), Concentra Group Holdings Parent, Inc. (CON)

Subbu Nambi

Guggenheim

$80.83→$120

Buy

66.44%

Upside

Reiterated

03/05/26

Guggenheim Keeps Their Buy Rating on BillionToOne, Inc. Class A (BLLN)

Andrew Brackmann

William Blair

―

Buy

―

Reiterated

03/05/26

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV), BillionToOne, Inc. Class A (NASDAQ: BLLN) and Solventum Corporation (NYSE: SOLV)

Mark Massaro

BTIG

$160→$140

Buy

94.17%

Upside

Reiterated

03/05/26

BillionToOne price target lowered to $140 from $160 at BTIGBillionToOne price target lowered to $140 from $160 at BTIG

Daniel Arias

Stifel Nicolaus

$145

Buy

101.11%

Upside

Reiterated

12/11/25

BillionToOne, Inc.: Strong Financial Performance and Strategic Market Positioning Drive Buy Rating

Tycho Peterson

Jefferies

$117

Hold

62.27%

Upside

Initiated

12/01/25

Balanced Outlook on BillionToOne, Inc.: High Growth Potential Amidst Competitive Challenges

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BillionToOne, Inc. Class A

3 Months

xxx

Success Rate

0/2 ratings generated profit

Average Return

-16.15%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -16.15% per trade.

1 Year

Subbu NambiGuggenheim

Success Rate

0/2 ratings generated profit

Average Return

-16.15%

Copying Subbu Nambi's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -16.15% per trade.

2 Years

xxx

Success Rate

0/2 ratings generated profit

Average Return

-16.15%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -16.15% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BLLN Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BLLN has received 8 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. BLLN average Analyst price target in the past 3 months is 124.00.

Each month's total comprises the sum of three months' worth of ratings.

BLLN Financial Forecast

BLLN Earnings Forecast

The previous quarter’s earnings for BLLN were $0.11.

BLLN Sales Forecast

The previous quarter’s earnings for BLLN were $96.05M.

BLLN Stock Forecast FAQ

What is BLLN’s average 12-month price target, according to analysts?

Based on analyst ratings, BillionToOne, Inc. Class A’s 12-month average price target is 124.00.

What is BLLN’s upside potential, based on the analysts’ average price target?

BillionToOne, Inc. Class A has 71.98% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BLLN a Buy, Sell or Hold?

BillionToOne, Inc. Class A has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.

What is BillionToOne, Inc. Class A’s price target?

The average price target for BillionToOne, Inc. Class A is 124.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $150.00 ,the lowest forecast is $90.00. The average price target represents 71.98% Increase from the current price of $72.1.

What do analysts say about BillionToOne, Inc. Class A?

BillionToOne, Inc. Class A’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of BLLN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

BillionToOne, Inc. Class A (BLLN) Stock Forecast & Price Target

BLLN Analyst Ratings

BLLN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering BillionToOne, Inc. Class A

BLLN Analyst Recommendation Trends

BLLN Financial Forecast

BLLN Earnings Forecast

BLLN Sales Forecast

BLLN Stock Forecast FAQ

Detailed List of Analyst Forecasts